Cite
Ocular Dorzolamide Nanoliposomes for Prolonged IOP Reduction: in-vitroand in-vivo Evaluation in Rabbits.
MLA
Kouchak, Maryam, et al. “Ocular Dorzolamide Nanoliposomes for Prolonged IOP Reduction: In-Vitroand in-Vivo Evaluation in Rabbits.” Iranian Journal of Pharmaceutical Research : IJPR, vol. 15, no. 1, Winter 2016, pp. 205–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=27610160&authtype=sso&custid=ns315887.
APA
Kouchak, M., Bahmandar, R., Bavarsad, N., & Farrahi, F. (2016). Ocular Dorzolamide Nanoliposomes for Prolonged IOP Reduction: in-vitroand in-vivo Evaluation in Rabbits. Iranian Journal of Pharmaceutical Research : IJPR, 15(1), 205–212.
Chicago
Kouchak, Maryam, Reza Bahmandar, Neda Bavarsad, and Fereydoun Farrahi. 2016. “Ocular Dorzolamide Nanoliposomes for Prolonged IOP Reduction: In-Vitroand in-Vivo Evaluation in Rabbits.” Iranian Journal of Pharmaceutical Research : IJPR 15 (1): 205–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=27610160&authtype=sso&custid=ns315887.